EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Anavex Life Sciences Corp. (AVXL) EBITDA Margin data is not available.
Income Statement Financials | |
-- |
|
$-47.51M |
|
-- |
|
-- |
|
$55.76M |
|
$-55.76M |
|
$8.26M |
|
$-47.50M |
|
$-47.50M |
|
$-47.51M |
|
$-47.51M |
|
$-47.51M |
|
$-47.51M |
|
$-55.76M |
|
$-55.76M |
|
79.79M |
|
79.79M |
|
$-0.60 |
|
$-0.60 |
|
Balance Sheet Financials | |
$154.39M |
|
-- |
|
-- |
|
$154.39M |
|
$12.53M |
|
-- |
|
-- |
|
$12.53M |
|
$141.85M |
|
$141.85M |
|
$141.85M |
|
82.07M |
|
Cash Flow Statement Financials | |
$-27.79M |
|
-- |
|
$29.65M |
|
$149.16M |
|
$151.02M |
|
$1.87M |
|
$16.37M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
12.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-27.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.49% |
|
-33.49% |
|
-30.77% |
|
-33.49% |
|
$1.73 |
|
$-0.35 |
|
$-0.35 |